share_log

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simpson Jennifer K.

Panbela Therapeutics | 4:持股变动声明-高管 Simpson Jennifer K.
美股SEC公告 ·  10/03 16:32
Moomoo AI 已提取核心信息
Jennifer K. Simpson, President and CEO of Panbela Therapeutics, Inc. [PBLA], was reported to have engaged in a transaction involving the company's stock on October 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report did not include information on the number of shares held by Simpson after the action.
Jennifer K. Simpson, President and CEO of Panbela Therapeutics, Inc. [PBLA], was reported to have engaged in a transaction involving the company's stock on October 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. The report did not include information on the number of shares held by Simpson after the action.
据报道,Panbela Therapeutics, Inc. [PBLA] 的总裁兼首席执行官Jennifer K. Simpson于2024年10月1日参与了一笔涉及公司股票的交易。公告中没有披露交易具体细节,包括股份数量、股票性质、交易价格以及股份总价值。交易的类型和状态也未提供。报告中也没有包含Simpson在交易后持有的股份数量信息。
据报道,Panbela Therapeutics, Inc. [PBLA] 的总裁兼首席执行官Jennifer K. Simpson于2024年10月1日参与了一笔涉及公司股票的交易。公告中没有披露交易具体细节,包括股份数量、股票性质、交易价格以及股份总价值。交易的类型和状态也未提供。报告中也没有包含Simpson在交易后持有的股份数量信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息